VAERS reports by lot

GSK Varicella/Shingles lot E3XT9: VAERS reports

45 VAERS reports list lot E3XT9 as a GSK Varicella/Shingles vaccine, received between 2024-06-11 and 2024-12-03. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
45
Reports
2%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2927%
General / Systemic (non-local)2523%
Neurological1110%
Dermatological (non-injection-site)109%
Allergic / Anaphylactic87%
Gastrointestinal87%
Musculoskeletal87%
Cardiac / Cardiovascular66%
Respiratory22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida10
District of Columbia5
Georgia3
Illinois2
Pennsylvania2
Indiana2
Minnesota2
Connecticut2
New York2
Massachusetts2
Ohio2
Delaware2

Reports by month received

2024-063
2024-0714
2024-0812
2024-097
2024-107
2024-111
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.